A therapy that XTL Biopharmaceuticals is developing for autoimmune diseases significantly reduced the expression of several cell signaling molecules called cytokines…
Articles by Ines Martins, PhD
Nektar Therapeutics dosed the first patient in its Phase 1 clinical trial evaluating NKTR-358 as a treatment for inflammatory and…
The Lupus Foundation of America (LFA) has unveiled its new National Resource Center on Lupus, a one-stop online…
Canada’s Aurinia Pharmaceuticals will report positive results from its 48-week AURION clinical trial evaluating voclosporin for lupus nephritis (LN) treatment. The…
The Lupus Foundation of America (LFA) has received the 2017 Paul G. Rogers Distinguished Organization Advocacy Award from…
Two years ago the Paleo Diet was the diet everyone was talking about. I remember going…
Actress, singer, and celebrity Selena Gomez, who came forward about her own struggles with lupus in 2015, has made a…
Neovacs will present an update on the company’s interferon alpha (IFNα) Kinoid vaccine program for lupus, dermatomyositis and type…
About 54 million Americans have been diagnosed with arthritis — a debilitating joint disease that takes many forms including lupus and rheumatoid…
Voclosporin has met complete and partial remission endpoints in a clinical trial in patients with lupus nephritis (LN), said Canada’s Aurinia Pharmaceuticals.